ARTICLE | Clinical News
Edoxaban: Completed Phase III enrollment
November 5, 2012 8:00 AM UTC
Daiichi Sankyo completed enrollment of more than 8,250 patients who have had an acute symptomatic DVT, PE or both in the double-blind, international Phase III Hokusai-VTE trial comparing 60 mg oral ed...